Plunkett's Biotech & Genetics Industry Trends & Statistics 2007 (Summary)

Published by: Plunkett Research, Ltd.

Published: Aug. 17, 2006 - 47 Pages

Table of Contents

Chapter 1: Major Trends Affecting the Biotech & Genetics Industry

1) A Short History of Biotechnology

2) The State of the Biotechnology Industry Today

3) Rising Interest in Ethanol as a Fuel gives Biotech a Boost

4) New Money Pours into Biotech Firms

5) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms

6) From India to Singapore to China, Nations Compete Fiercely in Biotech Development

7) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine

8) New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment—Many More Will Follow

9) Pharmaceutical Costs Soar in U.S., Controversy over Drug Prices Rages On

10) Biotech Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age

11) Biogenerics are in Limbo in the U.S.

12) Breakthrough Drug Delivery Systems Evolve

13) Stem Cells—Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race

14) Stem Cell Funding Trickles at the Federal Level While a Few States Create Funding of Their Own

15) Stem Cells—Therapeutic Cloning Techniques Advance

16) Stem Cells—A New Era of Regenerative Medicine Looms

17) Nanotechnology Converges with Biotech

18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy

19) Focus on Vaccines to Counter Potential Bioterror Attacks in the U.S.

20) Ethical Issues Abound

21) Technology Discussion—Genomics

22) Technology Discussion—Proteomics

23) Technology Discussion—Microarrays

24) Technology Discussion—DNA Chips

25) Technology Discussion—SNPs (“Snips”)

26) Technology Discussion—Combinatorial Chemistry

27) Technology Discussion—Synthetic Biology

28) Technology Discussion—Recombinant DNA

29) Technology Discussion—Polymerase Chain Reaction (PCR)

Chapter 2: Biotech & Genetics Industry Statistics

Biotech Industry Overview

Largest Global Pharmaceutical Companies

Profile of U.S. Public Biotech Companies, 2001-2005

U.S. Biotech Industry Financing, 1997-2005

Wage and Employment Estimates for Life, Physical and Social Science Employees in the Pharmaceutical Industry 2005

National Health Expenditure Amounts, By Type of Expenditure, U.S.: Selected Calendar Years 1980-2015

Global R&D Investments by Research-Based Pharmaceutical Companies: 1970-2005

U.S. National Science Foundation Biological Science Research Funding, Fiscal Year 2005-2007

U.S. Prescription Drug Expenditures, Percent Distribution and Per Capita Amount: Selected Calendar Years 1980-2015

A Closer Look at the Drug Discovery and Development Process

The U.S. Drug Discovery and Approval Process

Domestic R&D Spending as a Percentage of Domestic Sales, U.S. Research-Based Pharmaceutical Companies: Selected Years 1970-2005

Annual Percent Change in U.S. Research & Development Spending by Research-Based Pharmaceutical Companies, 1980-2005

R&D Spending By Function, U.S. Research-based Pharmaceutical Companies: 2004

U.S. FDA Approval Times for New Drugs 1993-2005

U.S. FDA Approval Times for New Molecular Entities (NMEs*), 1993-2005

U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME*) Approvals, 1993-2005

Total U.S. Biotechnology Patents Granted Per Year, 1989-2005

Generics' Share of the U.S. Drug Market 1984-2005

Global Agricultural Biotech At A Glance, 2005

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.